UNC-Chapel Hill Coronavirus Researcher Ralph Baric to Retire
The Assembly NC • • health
Key Points:
- Ralph Baric, a leading public-health researcher known for his work on coronaviruses and contributions to COVID-19 vaccine development, will retire from UNC-Chapel Hill in June.
- Baric has led pioneering research on vaccines and treatments for COVID-19, norovirus, and dengue fever, and has authored over 600 peer-reviewed papers during his career.
- His lab was among the first in the U.S. to receive a COVID-19 virus sample, contributing to FDA-approved treatments and the Moderna vaccine, but also became a focus of scrutiny and conspiracy theories regarding the virus's origins.
- Baric faced congressional questioning in 2024, with accusations linking his research to the Wuhan Institute of Virology, though he denies the virus originated in a lab and calls for a full investigation.
- Recently, Baric was placed on leave by UNC-CH amid investigations, and the U.S. Department of Health and Human Services is considering barring him from future research funding; he plans to contest these actions.